miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
The microRNA miR-101 is downregulated in several cancers, including bladder cancer. However, miR-101's role in the invasion, metastasis, and chemosensitivity of bladder cancer cells remains unclear. This study was conducted to determine miR-101's role on the lymphangiogenic molecule vascul...
Main Authors: | Ye Lei, Bin Li, Shiyu Tong, Lin Qi, Xiheng Hu, Yunbo Cui, Zengbo Li, Wei He, Xiongbing Zu, Zhi Wang, Minfeng Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4320037?pdf=render |
Similar Items
-
The VIM-AS1/miR-655/ZEB1 axis modulates bladder cancer cell metastasis by regulating epithelial–mesenchymal transition
by: Yaoyao Xiong, et al.
Published: (2021-04-01) -
Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway
by: Hong-Bo Li, et al.
Published: (2021-12-01) -
MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin.
by: Xin Zhang, et al.
Published: (2015-01-01) -
Correction to: Chemosensitizing and nephroprotective effect of resveratrol in cisplatin-treated animals
by: Abdel-Moneim M. Osman, et al.
Published: (2019-02-01) -
miR-378a-3p regulates glioma cell chemosensitivity to cisplatin through IGF1R
by: Wang Yunjiang, et al.
Published: (2021-11-01)